跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Demethylzeylasteral
首页
药物
Demethylzeylasteral
Demethylzeylasteral
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Potential application of demethylzeylasteral in resisting dengue virus infection
申请人: TIANJIN INT JOINT ACADEMY BIOMEDICINE
优先权: 2021
CN
Potential application of demethylzeylasteral in resisting mycobacterium tuberculosis infection
申请人: TIANJIN INT JOINT ACADEMY BIOMEDICINE
优先权: 2020
CN
Application of demethylzeylasteral in inhibition of NDM-1 enzyme activity
申请人: UNIV JILIN
优先权: 2024
CN
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES CONTAINING DEMETHYLZEYLASTERAL
申请人: SEOUL NAT UNIV R&DB FOUNDATION
优先权: 2022
US
Application of demethylzeylasteral to preparation of medicine for treating pancreatic cancer
申请人: ZHONGSHAN HOSPITAL FUDAN UNIV
优先权: 2016
CN
Application of demethylzeylasteral in preparation of medicine for treating acute myelogenous leukemia
申请人: UNIV CHONGQING MEDICAL
优先权: 2024
CN
Demethylzeylasteral Schiff base derivative and application thereof in preparation of anti-cancer drugs
申请人: UNIV SHANGHAI OCEAN
优先权: 2025
CN
Application of demethylzeylasteral in preparation of medicine for resisting methicillin-resistant staphylococcus aureus
申请人: EXPERIMENTAL RES CENTER CHINA ACADEMY OF CHINESE MEDICAL SCIENCES
优先权: 2025
CN
药物
反馈